Long-term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program.

Author: BitonVictor, HalfordJonathan J, RosenfeldWilliam E, SanderJosemir W, SteinhoffBernhard J, ToledoManuel

Paper Details 
Original Abstract of the Article :
OBJECTIVE: We determined retention on open-label cenobamate therapy in the clinical development program to assess the long-term efficacy and tolerability of adjunctive cenobamate in individuals with uncontrolled focal seizures. METHODS: Data from two randomized, controlled cenobamate studies and on...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299487/

データ提供:米国国立医学図書館(NLM)

Long-Term Retention of Cenobamate for Focal Seizures: A Promising New Treatment Option?

The world of epilepsy research is constantly evolving, and scientists are always seeking new ways to manage seizures. This study focuses on the long-term effectiveness and safety of cenobamate, a promising new treatment option for individuals with focal seizures. The researchers meticulously pooled data from various clinical trials to assess the retention rates of patients using cenobamate. Their findings suggest that cenobamate is a well-tolerated drug, with high retention rates observed over extended periods. This is encouraging news for individuals grappling with this challenging condition.

Cenobamate's Long-Term Efficacy: A Glimpse of Hope

The study revealed that the majority of participants who started cenobamate treatment continued using it for an average of 34 months. Specifically, 80% of patients were still using cenobamate after one year and 72% after two years, which is quite impressive. This indicates that cenobamate might provide a stable and effective solution for managing focal seizures in the long run.

Cenobamate's Impact on Everyday Life: A New Way to Live

These findings suggest that cenobamate could offer a new way to manage seizures, potentially improving the quality of life for patients. It's important to note that cenobamate, like any medication, may have potential side effects. However, the consistently high retention rates observed in this study point towards a favorable safety profile. Remember, it's crucial to discuss any concerns or potential side effects with your doctor and make informed decisions about your treatment plan.

Dr. Camel's Conclusion

This study offers a ray of hope for individuals struggling with focal seizures. Cenobamate's long-term efficacy and safety profile make it a compelling new treatment option. However, further research is needed to fully understand the long-term impact of cenobamate and its potential for individual patients. As with any medical treatment, it's crucial to have an open dialogue with your healthcare provider to determine the best course of action for your unique needs.

Date :
  1. Date Completed 2022-04-20
  2. Date Revised 2022-07-22
Further Info :

Pubmed ID

34813673

DOI: Digital Object Identifier

PMC9299487

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.